ClinicalTrialsFinder
RecruitingNCT05953402

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring

Sponsor

Bristol-Myers Squibb

Enrollment

1,182 participants

Start Date

Apr 21, 2026

Study Type

OBSERVATIONAL

Conditions

Ulcerative Colitis

Summary

The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with ulcerative colitis. The study is currently recruiting participants at 1 location. People eligible for this study include women.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

PPD Virtual - PPD - US

Wilmington, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05953402

Related Trials

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT000011841 location

BOOM-IBD2 Pivotal Clinical Trial

NCT0657166919 locations

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

NCT074631839 locations

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT064050871 location

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

NCT0718500940 locations